Free Trial

Qilian International Holding Group (BGM) Competitors

$12.84 +0.49 (+3.97%)
Closing price 03:59 PM Eastern
Extended Trading
$12.70 -0.14 (-1.09%)
As of 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BGM vs. PCVX, CYTK, KRYS, RYTM, PTCT, SRPT, RNA, SWTX, RARE, and AKRO

Should you be buying Qilian International Holding Group stock or one of its competitors? The main competitors of Qilian International Holding Group include Vaxcyte (PCVX), Cytokinetics (CYTK), Krystal Biotech (KRYS), Rhythm Pharmaceuticals (RYTM), PTC Therapeutics (PTCT), Sarepta Therapeutics (SRPT), Avidity Biosciences (RNA), SpringWorks Therapeutics (SWTX), Ultragenyx Pharmaceutical (RARE), and Akero Therapeutics (AKRO). These companies are all part of the "pharmaceutical products" industry.

Qilian International Holding Group vs.

Vaxcyte (NASDAQ:PCVX) and Qilian International Holding Group (NASDAQ:BGM) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, community ranking, earnings, risk and media sentiment.

Vaxcyte has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500. Comparatively, Qilian International Holding Group has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500.

Qilian International Holding Group has higher revenue and earnings than Vaxcyte.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VaxcyteN/AN/A-$402.27M-$3.99-8.51
Qilian International Holding Group$25.10M49.74-$1.44MN/AN/A

In the previous week, Vaxcyte had 16 more articles in the media than Qilian International Holding Group. MarketBeat recorded 16 mentions for Vaxcyte and 0 mentions for Qilian International Holding Group. Vaxcyte's average media sentiment score of 1.41 beat Qilian International Holding Group's score of 0.00 indicating that Vaxcyte is being referred to more favorably in the media.

Company Overall Sentiment
Vaxcyte Positive
Qilian International Holding Group Neutral

Vaxcyte received 55 more outperform votes than Qilian International Holding Group when rated by MarketBeat users.

CompanyUnderperformOutperform
VaxcyteOutperform Votes
55
78.57%
Underperform Votes
15
21.43%
Qilian International Holding GroupN/AN/A

96.8% of Vaxcyte shares are owned by institutional investors. 3.1% of Vaxcyte shares are owned by insiders. Comparatively, 58.7% of Qilian International Holding Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Qilian International Holding Group's return on equity of 0.00% beat Vaxcyte's return on equity.

Company Net Margins Return on Equity Return on Assets
VaxcyteN/A -23.53% -22.20%
Qilian International Holding Group N/A N/A N/A

Vaxcyte currently has a consensus target price of $136.50, suggesting a potential upside of 302.06%. Given Vaxcyte's stronger consensus rating and higher probable upside, analysts clearly believe Vaxcyte is more favorable than Qilian International Holding Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vaxcyte
0 Sell rating(s)
0 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
3.10
Qilian International Holding Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Vaxcyte beats Qilian International Holding Group on 8 of the 14 factors compared between the two stocks.

Get Qilian International Holding Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for BGM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BGM vs. The Competition

MetricQilian International Holding GroupPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$1.25B$6.48B$5.33B$8.39B
Dividend YieldN/A2.64%5.21%4.11%
P/E RatioN/A9.0626.7119.71
Price / Sales49.74251.50386.13120.55
Price / CashN/A65.8538.2534.62
Price / Book2.106.456.774.50
Net Income-$1.44M$143.98M$3.23B$248.22M
7 Day Performance11.46%2.41%1.80%0.56%
1 Month Performance15.21%4.56%11.10%13.17%
1 Year PerformanceN/A-2.67%17.11%7.30%

Qilian International Holding Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BGM
Qilian International Holding Group
N/A$12.84
+4.0%
N/AN/A$1.25B$25.10M0.00298Positive News
Gap Up
PCVX
Vaxcyte
3.0946 of 5 stars
$31.59
+1.4%
$136.50
+332.1%
-53.9%$4.08BN/A-6.87160Positive News
CYTK
Cytokinetics
4.1531 of 5 stars
$32.13
+1.4%
$74.44
+131.7%
-47.9%$3.84B$19.22M-5.97250
KRYS
Krystal Biotech
4.9093 of 5 stars
$139.43
+5.5%
$218.63
+56.8%
-24.1%$3.82B$333.45M46.63210Positive News
RYTM
Rhythm Pharmaceuticals
3.9428 of 5 stars
$58.97
+2.8%
$75.38
+27.8%
+64.2%$3.65B$136.86M-13.62140Positive News
PTCT
PTC Therapeutics
4.1848 of 5 stars
$46.01
+4.0%
$61.92
+34.6%
+18.9%$3.65B$1.77B-7.751,410Gap Up
SRPT
Sarepta Therapeutics
4.8153 of 5 stars
$36.37
+0.3%
$131.22
+260.8%
-69.0%$3.57B$2.23B29.10840Positive News
Analyst Forecast
High Trading Volume
RNA
Avidity Biosciences
1.9199 of 5 stars
$29.33
+5.2%
$66.38
+126.3%
+3.8%$3.53B$10.90M-10.18190Options Volume
SWTX
SpringWorks Therapeutics
2.3665 of 5 stars
$46.12
-0.3%
$52.57
+14.0%
+7.5%$3.46B$191.59M-13.25230High Trading Volume
RARE
Ultragenyx Pharmaceutical
3.9707 of 5 stars
$36.09
+2.8%
$90.93
+152.0%
-12.7%$3.32B$590.69M-5.691,310Positive News
AKRO
Akero Therapeutics
3.8137 of 5 stars
$41.53
+4.2%
$76.29
+83.7%
+138.9%$3.31BN/A-11.0730Insider Trade
High Trading Volume

Related Companies and Tools


This page (NASDAQ:BGM) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners